Prognostic restaging after treatment initiation in patients with AL amyloidosis

The utility of systemic light chain (AL) amyloidosis staging systems has been validated for newly diagnosed patients, but their role in restaging after treatment has not been explored. We designed this study to evaluate whether the currently used systems are of prognostic value at 3 and 6 months of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Adv
Huvudupphovsmän: Abdallah, Nadine, Dispenzieri, Angela, Muchtar, Eli, Buadi, Francis K., Kapoor, Prashant, Lacy, Martha Q., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Hayman, Suzanne R., Leung, Nelson, Dingli, David, Lust, John A., Go, Ronald S., Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A., Kumar, Shaji K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2021
Ämnen:
Stimulus Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903228/
https://ncbi.nlm.nih.gov/pubmed/33595624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003782
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk